Plasmid Costs Explain Plasmid Maintenance, Irrespective of the Nature of Compensatory Mutations.
adaptation
antibiotic resistance
computer simulations
conjugation
conjugative plasmids
fitness cost
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
01 May 2023
01 May 2023
Historique:
received:
08
04
2023
revised:
27
04
2023
accepted:
28
04
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
Conjugative plasmids often carry virulence and antibiotic-resistant genes. Therefore, understanding the behavior of these extra-chromosomal DNA elements gives insights into their spread. Bacteria frequently replicate slower after plasmids' entry, an observation inconsistent with the plasmids' ubiquity in nature. Several hypotheses explain the maintenance of plasmids among bacterial communities. However, the numerous combinations of bacterial species and strains, plasmids, and environments claim a robust elucidatory mechanism of plasmid maintenance. Previous works have shown that donor cells already adapted to the plasmid may use the plasmid as a 'weapon' to compete with non-adapted plasmid-free cells. Computer simulations corroborated this hypothesis with a wide range of parameters. Here we show that donor cells benefit from harboring conjugative plasmids even if compensatory mutations in transconjugant cells occur in the plasmid, not on chromosomes. The advantage's leading causes are as follows: mutations take time to appear, many plasmids remain costly, and re-transfer of mutated plasmids usually occurs in sites distant to the original donors, implying little competition between these cells. Research in previous decades cautioned against uncritical acceptance of the hypothesis that resistance cost helps to preserve antibiotics' effectiveness. This work gives a new twist to this conclusion by showing that costs help antibiotic-resistant bacteria to compete with plasmid-free cells even if compensatory mutations appear in plasmids.
Identifiants
pubmed: 37237742
pii: antibiotics12050841
doi: 10.3390/antibiotics12050841
pmc: PMC10215365
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nat Rev Microbiol. 2006 Aug;4(8):597-607
pubmed: 16845430
Nature. 1983 Apr 21;302(5910):725-6
pubmed: 6835408
Int Microbiol. 2023 Jan;26(1):1-9
pubmed: 36224500
Microorganisms. 2023 May 08;11(5):
pubmed: 37317212
PLoS Genet. 2021 Jul 12;17(7):e1009656
pubmed: 34252089
Nature. 1988 Sep 22;335(6188):351-2
pubmed: 3047585
Microbiol Spectr. 2017 Sep;5(5):
pubmed: 28944751
Evol Appl. 2012 Nov;5(7):757-61
pubmed: 23144661
Microbiology (Reading). 2007 Aug;153(Pt 8):2803-2816
pubmed: 17660444
Plasmid. 2019 Mar;102:29-36
pubmed: 30771401
Trends Microbiol. 2023 Jun;31(6):559-570
pubmed: 36720668
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Nature. 1983 Dec 8-14;306(5943):616-7
pubmed: 6316165
Philos Trans R Soc Lond B Biol Sci. 2022 Jan 17;377(1842):20200473
pubmed: 34839709
Antimicrob Agents Chemother. 2009 Jun;53(6):2227-38
pubmed: 19307361
Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4940-E4949
pubmed: 29735666
Genetics. 2000 Aug;155(4):1505-19
pubmed: 10924453
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
J Theor Biol. 2012 Feb 7;294:144-52
pubmed: 22085738
Nat Ecol Evol. 2020 Jun;4(6):863-869
pubmed: 32251388
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17162-7
pubmed: 15569938
Genome Biol Evol. 2019 Oct 1;11(10):3022-3034
pubmed: 31539047
EXS. 1994;69:479-93
pubmed: 7994120
ISME J. 2008 Oct;2(10):1024-39
pubmed: 18528415
Plasmid. 2017 Sep;93:24-29
pubmed: 28842131
Plasmid. 2017 Sep;93:17-23
pubmed: 28842133
Plasmid. 2017 Sep;93:6-16
pubmed: 28842132
Nat Commun. 2020 Jul 17;11(1):3602
pubmed: 32681114
Philos Trans R Soc Lond B Biol Sci. 2022 Jan 17;377(1842):20200463
pubmed: 34839712
mSystems. 2019 Jan 15;4(1):
pubmed: 30944871